The Donald is Back. Should the Industry Throw a Parade or Run for the Hills?

Donald Trump King of Marijuana

When voters delivered a second term to Donald Trump, it’s unlikely the counterculture industry was at the top of their minds.

Let’s hope it wasn’t, anyway.

While Trump carried all seven swing states and the popular vote, the red wave that swept him into office also delivered a stinging rebuke to drug reform advocates. Legalization efforts in both Dakotas as well as Florida failed, and Massachusetts rejected a measure to make psychedelics great again.

On election night, it was hard for many to see a positive outlook for smoke shops.
Others, however, had a different take. Trump supporters within the industry were quick to point out that the President-elect ran on a pro-cannabis, pro-vape platform. He championed the Florida ballot initiative in brazen defiance of the state’s popular Republican governor and tweeted out support for moving cannabis down to Schedule 3.

In a Truth Social post in September, Trump’s account noted: “I believe it is time to end needless arrests and incarcerations of adults for small amounts of marijuana for personal use. We must also implement smart regulations while providing access for adults to safe, tested product.”

Still, it’s hard to believe that cannabis reform is high on his agenda.

Reasons for Pessimism

The famously mercurial President is an avid poll watcher. He understands, like few others, what words and actions get responses from the public.

And while he’s publicly supported much-needed reforms, he was also glued to the TV as news of cannabis’s failure at the ballot box rolled in. For a president who loves being on the winning side of every issue, the defeat of initiatives he promoted might sting.

There’s also the specter of his first administration. Before the 2016 election, Trump promised to leave cannabis matters to the state, but he didn’t stick to it. His administration proudly reversed the Obama-era policy that prevented federal prosecutors from going after cannabis dispensaries in legalized states and later proposed cutting off all federal protections of state medical marijuana laws.
It’s hard to erase the memory of that bait and switch.

And sure, he crowed support on Truth Social. But it’s clear Trump didn’t write that. He may have OK’d the messaging, but the post lacks the President’s singular voice and energy, signaling that a pro-cannabis stance might not be that important to him.

Even Vice President J.D. Vance, despite penning an autobiography cataloging his intimate experience with opioid addiction, is an opponent of cannabis. When nearly 60 percent of voters in his state voted to legalize recreational usage in 2023, Vance stood firm in his disagreement.

There’s also the matter of Congress. The incoming Senate Majority Leader, John Thune, has long voiced criticism of the cannabis industry. He also hails from South Dakota, where voters are fresh from shooting down a legalization initiative.
Even if Trump wants to implement a forward-thinking cannabis agenda, it feels unlikely he’ll choose to spend his political capital in that arena when he has so many other causes that ignite his passion.

Reasons for Optimism

On the other hand, Trump has vowed that his second term will look and feel different from his first. And, if the people he surrounds himself with are any indication, that certainly seems true.

Trump changed up his inner circle to include a cadre of pro-cannabis advisors. On the campaign trail, he’s gotten closer to Rep. Matt Gaetz2, Elon Musk, Dr. Oz, and Robert F. Kennedy Jr., all of whom have expressed hearty support for cannabis or psychedelics.

With key administration figures openly embracing alternative therapies, the atmosphere within the Oval Office could feel more amenable to forward-thinking policies around cannabis.

Trump has also shown a fondness for accomplishing things his opponents couldn’t. That could bode well for federal legality. The Biden administration proposed rescheduling cannabis to a Schedule 3 drug in 2022, but the effort stalled out before it reached final approval, with bureaucrats ultimately deciding to put the issue on hold until the new administration arrives. Perhaps Trump II will see this as a chance to demonstrate he’s more effective than his predecessor.

What the Counterculture Should Expect?

If there’s a through line when it comes to President Trump’s cabinet picks and policy proposals, it’s a mistrust for the status quo. Sometimes, the ideas espoused by those close to the President tend to the conspiratorial, more often they’re simply mistrustful of what they see as government overreach and interference.

Several figures in Trump’s cabinet have expressed feelings that federal agencies have become captured by corporate interests like Big Pharma or that administrative bloat hampers efficiency and effectiveness.

Those are ideas the counterculture industry can get behind. But, like all complex matters, the trouble isn’t with the diagnosis. It’s the prescription. And on that front, the news is . . . complicated.

While it’s tempting to take a stab at parsing Trump’s words, it doesn’t seem likely that he has a regimented “cannabis plan” that he’s trying to articulate. The issue just doesn’t seem that important to the man. A better way to predict the future is to scrutinize his actions.

Trump has signaled a willingness to blow up the whole operation and start again. It sounds far out, but we’ve seen it before. Jimmy Carter turned the federal budget on its ear with his zero-base budgeting framework. Ronald Reagan rode in on a promise to shrink the government and eliminate the Departments of Energy and Education but ended up creating a new department and increasing the number of non-military federal workers.

While ideas like the Department of Government Efficiency and the outside-the-beltway perspectives Trump came in with might feel different at first, it’s possible that his radical plans will ultimately feel … a bit ordinary, especially when it comes to cannabis reform.

The biggest changes to come may come from aspects of the industry that aren’t related to cannabis: tariffs on foreign-made goods and whatnot. With the President focused on effecting a MAGA-style government reformation, it’s likely that low-priority concerns like cannabis banking bills will have difficulty getting any oxygen.

Maybe the more things change, the more they’ll stay the same.

Recent Articles

Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.
State-sanctioned medical and recreational cannabis programs benefit the average user in many ways. Still, they remain a double-edged sword for dispensary owners, greenhouse growers, and others who earn their living from the cannabis industry. There are plenty of profits to be had, sure, but how exactly are you expected to secure your cash or process electronic transactions when banks refuse to work with you?